1. Largest U.S. cannabis firms form U.S. Cannabis Roundtable to advocate for reform. 2. Group represents 450,000 employees and 13,000 dispensaries across 38 states. 3. Lobbying aims to reclassify cannabis from Schedule I to Schedule III. 4. Younger Republicans and Trump may favor cannabis legalization initiatives. 5. Past efforts for cannabis banking reforms have repeatedly stalled in Congress.
The formation of a powerful advocacy group could advance cannabis reforms, positively affecting cannabis stocks. A similar situation in the past saw stock spikes following legislative progress.
The article directly discusses actions and potential changes that can substantially impact the cannabis industry, including CL’s stock price. The establishment of a influential lobbying group indicates a shift in industry dynamics.
Reforms may take time; however, the group’s sustained lobbying efforts could yield results over time. Past efforts indicate that incremental change is common in such sectors.